JO
COCP icon

John Overdeck’s Cocrystal Pharma COCP Stock Holding History

John Overdeck’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Buy
+175,379
New +$216K ﹤0.01% 4808

Other funds holding COCP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

John Overdeck's COCP Position: Q2 2026 in Review

John Overdeck opened a new position in Cocrystal Pharma (COCP) in Q2 2026: 175,379 shares worth $184K. The stake represents ﹤0.01% of the portfolio and ranks #4808 among its holdings.

27 funds tracked by Wall St. Rank hold COCP as of Q2 2026.

  • John Overdeck held 175,379 shares of Cocrystal Pharma worth $184K as of Q2 2026.
  • Cocrystal Pharma was a new John Overdeck position in Q2 2026.
  • Cocrystal Pharma made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4808 holding.
  • 27 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.